Skip to content

Inflammation signals heart disease risk in people with HIV

South Africa: Budgeting failures threaten ARV programme

Deaths in older children, teenagers with HIV set to grow in southern Africa

GS-9350 boosts atazanavir just as well as ritonavir

Tobacco, marijuana and alcohol may lower levels of some anti-HIV drugs

Dual maintenance therapy with atazanavir plus raltegravir sustains viral suppression

Once-daily Kaletra approved in the European Union

Boosted protease inhibitor regimens with 3TC work despite M184V resistance

Maturation inhibitor bevirimat is well tolerated and effective in predicted responders